Uniphar PLC AGM Statement (0016Z)
11 May 2023 - 4:00PM
UK Regulatory
TIDMUPR
RNS Number : 0016Z
Uniphar PLC
11 May 2023
AGM Statement
Dublin, London | 11 May 2023
Uniphar plc (the "Group" or "Uniphar") is holding its AGM today
at 11am BST at the office of William Fry, LLP, 6th Floor, 2 Grand
Canal Square, Dublin 2, D02 A342, Ireland.
At the AGM, Maurice Pratt, Chairman of Uniphar, will make the
following statement:
"I am pleased to say that 2022 was another successful year for
Uniphar, with further progress made towards our financial and
strategic objectives. The Group delivered a strong financial
performance, in line with the Board's expectations. Building on our
robust performance in the previous year, the Group delivered 5.7%
organic gross profit growth, with organic growth across all
divisions and an outperformance in our Supply Chain & Retail
division. EBITDA increased to EUR98m reflecting reported growth of
13.4% and the Group ended the year with strong liquidity and modest
leverage of 1.0x, underpinning the Group's disciplined approach to
capital allocation and cash conversion.
During the year, we continued to make significant strategic
progress across each division and enhanced our platforms through
both organic investment and M&A that will ensure continued,
resilient growth through 2023 and beyond:
-- In Product Access, the acquisitions of BModesto Group and
Orspec Pharma provide significant capability across continental
Europe and the Asia Pacific region. These assets, which we will
continue to invest in, add significant scale and reach to our
global Product Access platform.
-- In Commercial & Clinical, Boston headquartered Inspired
Health broadens our service offering through high value market
research consultancy services. We also progressed our European
commercialisation platform through an organic investment in a
highly skilled pan-European Medical Affairs team.
-- In Supply Chain & Retail, the acquisition of McCauley
Pharmacy Group, who are the Irish market leaders in health,
wellbeing and beauty products, adds significant capability to our
higher margin retail offering. We also announced a multi-year
investment in a new distribution facility which will future-proof
our Supply Chain & Retail business and support future growth
across the wider Group.
Uniphar has traded in line with the Board's expectations in the
first four months of 2023 and remains well positioned to deliver
organic gross profit growth across all divisions and to deliver on
expectations for the full year.
Sustainability continues to form a key part of Uniphar's culture
and business practices. Initiatives such as our hugely successful
Unity for Hope charity event, and the launch of our two Employee
Resource Groups - the Rainbow Alliance and the Women's Alliance
demonstrate our commitment to creating a sustainable workplace. Our
teams also made progress under our Environmental pillar, improving
our carbon footprint initiatives and focusing on ways to further
decarbonise our business. We completed our first Scope 3
assessment, highlighting the opportunity for a collaborative
approach with our suppliers to reduce our collective impact on the
environment. Finally, our commitment to maintaining the highest
standards of corporate governance across the Group continued in
2022, where the Board adopted the UK Corporate Governance Code,
achieving another important milestone on our journey as a publicly
quoted company.
The continued success of the business in 2022 could not have
been delivered without the commitment, ingenuity and "can-do"
spirit of our Uniphar colleagues worldwide, who continued to
deliver for our customers, the pharmacies, hospitals, manufacturers
and patients we serve throughout 2022, while navigating the various
challenges presented during the period, including unprecedented
global cost inflation and supply chain disruption.
I would like to thank all of our Uniphar colleagues, management
and my fellow Directors for the huge effort they have put in over
the past 12 months, and for their continued dedication and
commitment. Finally, I would like to thank our shareholders,
executive team and all our teams worldwide for their loyalty, hard
work and dedication during 2022."
--- ENDS ---
For further details contact:
Uniphar Group Tel: +353 (0) 1 428 7777
Allan Smylie, Head of Strategy and IR
Davy (Joint Corporate Broker, Nominated Advisor Tel: +353 (0) 1 679 6363
and
Euronext Growth Listing Sponsor)
Daragh O'Reilly
Niall Gilchrist
Ivan Murphy
RBC Capital Markets (Joint Corporate Broker) Tel: +44 (0) 20 7653
4000
Jonathan Hardy
Jamil Miah
Stifel Nicolaus Europe Limited (Joint Corporate Tel: + 44 (0) 20 7710
Broker) 7600
Matt Blawat
Ben Maddison
Francis North
Q4 PR Tel: +353 (0) 1 475 1444
Iarla Mongey, Public Relations Advisor to Uniphar
Group
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGMFLFSEEAIILIV
(END) Dow Jones Newswires
May 11, 2023 02:00 ET (06:00 GMT)
Uniphar (LSE:UPR)
Historical Stock Chart
From Apr 2024 to May 2024
Uniphar (LSE:UPR)
Historical Stock Chart
From May 2023 to May 2024